86 related articles for article (PubMed ID: 15681489)
21. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
22. [Vascular endothelial growth factor--structure and functions].
Barańska P; Jerczyńska H; Pawłowska Z
Postepy Biochem; 2005; 51(1):12-21. PubMed ID: 16209337
[TBL] [Abstract][Full Text] [Related]
23. Peptide-based molecules in angiogenesis.
D'Andrea LD; Del Gatto A; Pedone C; Benedetti E
Chem Biol Drug Des; 2006 Feb; 67(2):115-26. PubMed ID: 16492159
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic perspectives in bronchial vascular remodeling in COPD.
Zanini A; Chetta A; Olivieri D
Ther Adv Respir Dis; 2008 Jun; 2(3):179-87. PubMed ID: 19124370
[TBL] [Abstract][Full Text] [Related]
25. A defective angiogenesis in chronic kidney disease.
Futrakul N; Butthep P; Laohareungpanya N; Chaisuriya P; Ratanabanangkoon K
Ren Fail; 2008; 30(2):215-7. PubMed ID: 18300124
[TBL] [Abstract][Full Text] [Related]
26. [Angiogenesis in the chronic inflammatory diseases and malignancies].
Mizia-Malarz A; Sobol G; Woś H
Pol Merkur Lekarski; 2008 Mar; 24(141):185-9. PubMed ID: 18634281
[TBL] [Abstract][Full Text] [Related]
27. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
29. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
30. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
[TBL] [Abstract][Full Text] [Related]
31. VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype.
Nagy JA; Senger DR
Exp Cell Res; 2006 Mar; 312(5):538-48. PubMed ID: 16310771
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis and platelets: the clot thickens further.
Blann AD
Cardiovasc Res; 2004 Aug; 63(2):192-3. PubMed ID: 15249175
[No Abstract] [Full Text] [Related]
33. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
35. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
36. Tumour-associated angiogenesis in human colorectal cancer.
Rmali KA; Puntis MC; Jiang WG
Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
[TBL] [Abstract][Full Text] [Related]
37. Role of vascular endothelial growth factor in prostate cancer.
Delongchamps NB; Peyromaure M; Dinh-Xuan AT
Urology; 2006 Aug; 68(2):244-8. PubMed ID: 16904427
[No Abstract] [Full Text] [Related]
38. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
Thejass P; Kuttan G
Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
[TBL] [Abstract][Full Text] [Related]
39. [Angiogenesis and diabetic retinopathy: specific connections to neuroretinal tissue].
Paques M; Massin P; Bonnel S; Sahel JA
Journ Annu Diabetol Hotel Dieu; 2005; ():33-7. PubMed ID: 16161303
[No Abstract] [Full Text] [Related]
40. Functional significance of apoptosis in chronic obstructive pulmonary disease.
Park JW; Ryter SW; Choi AM
COPD; 2007 Dec; 4(4):347-53. PubMed ID: 18027162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
